CA2087691A1 - Cosmetic compositon - Google Patents

Cosmetic compositon

Info

Publication number
CA2087691A1
CA2087691A1 CA002087691A CA2087691A CA2087691A1 CA 2087691 A1 CA2087691 A1 CA 2087691A1 CA 002087691 A CA002087691 A CA 002087691A CA 2087691 A CA2087691 A CA 2087691A CA 2087691 A1 CA2087691 A1 CA 2087691A1
Authority
CA
Canada
Prior art keywords
cosmetic composition
composition according
component
group
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002087691A
Other languages
French (fr)
Inventor
Peter Critchley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unilever PLC
Original Assignee
Unilever PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929201476A external-priority patent/GB9201476D0/en
Priority claimed from GB929226690A external-priority patent/GB9226690D0/en
Application filed by Unilever PLC filed Critical Unilever PLC
Publication of CA2087691A1 publication Critical patent/CA2087691A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14Liposomes; Vesicles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • A61K8/553Phospholipids, e.g. lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8105Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • A61K8/8111Homopolymers or copolymers of aliphatic olefines, e.g. polyethylene, polyisobutene; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/007Preparations for dry skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/002Preparations for repairing the hair, e.g. hair cure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)

Abstract

ABSTRACT

COSMETIC COMPOSITION

A cosmetic composition effective in the reduction of water loss through the stratum corneum comprising three components A, B and C, wherein A is a molecule having at least two hydrocarbon chains and a polar head group for which:

.
Component B is a molecule having one long hydrocarbon chain and a polar head group; and component C is capable of stabilising any lipid bilayers assisting the formulation of lipid bilayers and formed in the composition; providing that the molar ratio of A:B:C is 1:1.5 to 6.0:1.1 to 8Ø

Description

2~7~9~

- 1 - J32a~7 ~E12~MPO,S I TI ON

FIELD OF THE INVENTION

This invention relates to cosmetic compositions and particularly compositions concerned with the prevention or amelioration of skin wrinkling, chapping or ageing.

BACKGROUND TO THE INVENTION AND PRIOR ART
It is generally understood that ceramides present within the intercellular lipid lamellae of the stratum corneum play an important role in the production and maintenance of the water permeability barrier of the skin.
Ceramides, or substances closely related to them, have been disclosed as components of skin ~are compositions. In particular, Kao Corporation in GB 2 178 312 and GB 2 213 723 discloses the use of natural ceramides extracted from skin in products for topical application.
Also, Kao Corporation in EP 227 994 and EP 282 816 discloses the use of synthetic ceramides, which are similar to their natural counterparts found in skin.

It is also known that in addition to ceramides the lipid lamellae comprises sterols and fatty acids N Y
Schurer, P M Elias (1991) Adv Lip Res 24 27-56 Acad Press.

, . . . .

. . .

; ~
- - . .
.

. " ~. . . : ,. : .
, ~8~

It is believed that one of the causes of dry skin and ageing skin is a reduction in the amount of lipid contained within these intercellular lipid lamellae. It is therefore clesirable to be able to successfully replace these depleted lipids by the topical route.

One suitable method for testing the abi].ity o~
cosmetic compositions to effect the desired repair of the water barrier layer (ie the intercellular lipid lamellae) is to study the ability of the cosmetic composition to reduce water loss through the stratum corneum. Although previously proposed cosmetic compositions have shown a nominal level of water loss reduction, the composition according to the present invention shows a significankly improved ability for such a water loss reduction and hence provides a much more efective control of water loss and/or repair of damaye to the water barrier layer in the stratum corneum.

It has been shown in Chapter 16 entitled "Aggregation of Amphiphilic Molecules into Micelles, ~ilayers, Vesicles and Biological Membranes" in Intermolecular and Surface Forces, (1985) Jacob N Isrealachvili, ed Acad Press that suitable lipids for forming a bilayer are those having a polar head group and at least two hydrocarbon chains, such that there exists a clearly defined relationship between the volume occupied by the hydrocarbon chains and the optimum area occupied by the polar head group. This relationship is that:
V should be greater than 0.5 but aOlc less than or equal to 1.0 where V is the volume of the hydrocarbon chains lc is the critical length of the hydrocarbon chains aO is the optimum area of the polar head group , , , 2~7~1 - 3 - ~32~7 DEFINITION OF _HE VENTION

The invention provides a cosmetic composition comprising three components A, B and C, wherein A is a molecule having at least two hydrocarbon chains and a polar head group for which V ~ 0.5 :~ 1.0; component aOlc B is a molecule having one long hydrocarbon chain and a polar head group; and component C is capable of assisting the formation of lipid bilayers and stabilising any lipid bilayers formed in the composition; providing that the molar ratio of A:B:C is 1:1.5 to 6.0:1.1 to 8Ø

DISCLOSURE OF THE INVENTION
The invention provides a composition suitable for topical application to the skin. The site of action of the composition is in the stratum corneum of the skin, and its mode of action is to effectively control water loss and/or to repair damage to the water barrier layer in tha stratum corneum.

Component A

Component A is a molecule having at least two hydrocarbon chains and a polar head group, providing that the volume occupied by the hydrocarbon chains and the area occupied by the polar head group fulfils the relationship V > 0.5 < 1.0 aOlc where V, lc and aO are as defined above.

Preferably the hydrocarbon chains each have at least 14 carbon atoms. Furthermore it is preferred that hydrocarbon chains having less than 16 carbon atoms are fully saturated, however, hydrocarbon chains having more than 16 carbon atoms may contain 1 to 3 unsaturations if desired.

:

:

r~ ~ ~ J

_ ~, _ J3247 Suitable polar head groups may be selected from residues such as phosphates, phosphonates, sulphates, sulphonates, sulphones, hydroxyl, ethylene oxide, carboxyl and mixtures thereof. Preferably the polar head group is selected from hydroxyl groups, ethylene oxide units, carboxyl groups and mixtures thereof.

Suitable compounds that may be selected as component A are ceramides; pseudoceramides; phospholipids;
1~ glycolipids having a structure of t:wo or more acyl or alkyl long chains suitably containing from 14 to 50 carbon atoms each, attached to a polar group; specific esters of polyethylene glycol; polyglycerol -n-x oleate (CAS 9007-48~
1); sorbitan dioleate (CAS 29116-98-1); sorbitan sesquioleate (CAS 8007-43-0); long chain alkyl ether versions of phospholipids and glycolipids; and mixtures thereof.

Ceramides Ceramides are preferably selected from ceramides having the general structure (1) R ~ (CHORz) m - C - NH
CH - CH20R4 (1 Rl - A - CHOR3 where A represents - CH2 -; - CHOR5 -; - CH=CH - or - CHOY -R represents a linear or branched, saturated or unsaturated aliphatic hydrocarbon group having from 1 to 49-carbon atoms, preferably from 12 to 49 carbon atoms, or a subgroup (2).

y _ o - (CaHb) (2) .,, , ;

: : :

, 7~

R1 represents a linear or branched, saturated or unsaturated aliphatic hydrocarbon group having ~rom 8 to 28 carbon atoms, preferably from 13 to 28 carbon atoms;

R2, R3 and X5 individually represent H, a phosphate residue or a sulphate residue;

R4 represents H, a phosphate residue, a sulphate residue or a sugar residue;
a is an integer of f~om 7 to 4g, preferably from ~2 to 49 b is an integer of from 10 to 98, preferably from 2~ to 98 m i5 0 or 1 Y represents H or a residue of a C14.22 fatty acid having the general structure (3) o _ g - (CXHyZz) CH3 (3 where Z is - OH or an epoxy oxygen x is an integer of from 12 to 20 y is an integer of from 20 to 40 and z is 0 or an integer of from 1 to 4 Ceramides having the general structure (1) are naturally occurring and can be isolated from a suitable plant source or from animal tissue such as pig skin or neural tissue. Ceramides can also be synthesised.

Particular preferred examples of ceramides are ceramide I and ceramide II.

.. . ..
:- . ,;. :

: , :, : ~. ~ . :

~7~
- 6 - J32~7 Pseu oceramides Pseudoceramides are preferably selected froln pseudoceramides (ia synthetic ceramide like structure~) having the general structure (4):
o R8 Il I
R6 - ( CHOH ) n - C - N - CH2 fHORy R7 - (P,) p where B represents - OCH2 ~ or CHOH.

R6 represents a linear or branched, saturated or unsaturated aliphatic hydrocarbon group having from 1 to ~9 carbon atoms preferably from 12 to 49 carbon atoms or the subgroup (2).

R7 represents a linear or branched, saturated or unsaturated aliphatic hydrocarbon group having from 8 to 28 carbon atoms preferably from 13 to 28 carbon atoms.
R8 represents H, or a subgroup - (CH2)CCOOH, where c is an integer of from 1 to 6, or a subgroup having the structure (5).

~X1- X3 I I
- ( CH2 ) d ~ - C _ - CHOH (5) _X2 - ' e whera Xl, X~ and X3 each individually represent ~, a Cl5 alkyl or a Cl5 hydroxyalkyl;

:~

" , -:

.

g7~9~
- 7 ~ J32~7 d is 0 or an integer of from 1 to 4 e is 0 or 1 n is 0 or 1 and p is 0 or 1;

R9 represents H, a phosphate residue, a sulphate residue or a sugar residue.

PhospholiPids Phospholipids may be advantageously used because th~y are derivahle from plant sources. An example of a suitable phospholipid material is a mixture of phospholipids derived from a particular fraction in a continuous soya bean phospholipid extraction and is sold under the trade name Ceramax by Quest International of Ashford, Kent, UK.

Glycolipids Suitable glycolipids are those having a structure of two or more acyl or alkyl long chains suitably containing from 14 to 50 carbon atoms each, attached to a polar head group. The polar head group may be selected from residues such as phosphates, phosphonates, sulphates, sulphonates, sulphones, hydroxyl, ethylene oxide, carboxyl and mixtures thereof. Preferably the polar head group is hydroxylated.

Suitable examples are glycosyl glycerides or diacyl or dialkyl saccharides, eg sucrose diesters with two or more long chain ester groups. An example of the latter type of material is obtainable from Ryoto under the appellation Ryoto sugar esters such as Ryoto sugar ester S270, and S1570.

~o~7~1 - 8 - ~32~7 Esters of PolYethylene Glycol Suitable esters are:

(i) succinic acid esters having t:he general structure (6) o Rl 1 R12 Il l l 11 RlUO(Cq~2qO)fC - cH - CH - C - (OCqH2q~9 -- OR13 (6) in which R10 represents an alkyl, alkenyl, mono- or dihydroxyalkyl or hydroxyalkenyl group having from 6-22 carbon atoms;

Rll and Rl2 individually represent H or an alkyl or alkenyl group having from 12 to 22 carbon atoms; providing that when Rll is ~, R12 is an alkyl or ~lkenyl group and when R12 is H, Rll is an alkyl or alkenyl group;

Rl3 represents hydrogen, an alkyl, alkenyl, mono- or dihydroxyalkyl or hydroxyalkenyl group having from 6 to 22 carbon atoms or the group (7~:

R12 Rll O
- C - CH - CH - C - (CqH2qO3f - ORlo (7) q is an integer of from 2 to 3 f and g are average degrees of alkoxylation, namely f is from 0 to 20 and g is from 1 to 20.

In structure (6), the group R13 preferably represents H, while the group Rlo preferably represents an alkyl group having from 16 to 22 carbon atoms and most preferably from 20 to 22 carbon atoms.

Also with reference to structure (6), q is preferably 2 and (f+g) is preferably from 1 to 20.

: .~ , , . , , . : ,,.,,; . :

9 ~
_ 9 _ J3~47 Such succinic acid esters are synthesised using known methods of preparative chemistry, these methods are described in our co-pending patent application GB 9223578.7 filed 11 November 1992.

(ii~ Polyethylene glycol r-dilaurate (CAS 9005-02-1) and polyethylene glycol r-distearate (CAS 9005-08-7).

(iii~Polyethylene glycol r-distearammorlium chlorides.
These may be derived from polyethylene glycol r-tallow amine (CAS 61791) by alkylating the nitrogen with an alkyl halide having more than 8 carbon atoms.

(iv) Polyethylene glycol derivatives of long chain alkyl derivatives of malic, tartaric, maleic, malonic and glyceric acid.

where r is the number of ethylene oxide groups within the molecule and is preferably from 1 to 8, most preferably from 2 to 4.

Preferably component A comprises a mixture of the above mentioned compounds. More preferably this mixture is such that a range of chain lengths are present. Most preferred are mixtures of ceramide and phospholipids, particularly the phospholipid mixture having the trade name Ceramax, wherein the ratio of ceramide to Ceramax is from 1:1000 to l:l! preferably from 1:50 to 1:1 and most preferably from 1:10 to 1:5 by weight.
Component B

Component B is a molecule having one long hydrocarbon chain and a polar head group. A wide variety of simple co-surfactants are functional. Preferred co-surfactants are straight-chained mono carboxylic acids having 14 to 30 carbon atoms, straight-chained fatty alcohols having 14 to .
`. `~

- 10 - J32~7 carbon atoms, sugar esters, alkylated sugars and mixtures thereof.

Examples of suitable sugar est:ers and alkylated sugars are monopalmitoyl or 6~cetyl glucose and ~ or ~ methyl 6-cetyl glucoside.

Pre~erably the co-surfactants are chosen from straighk chained mono-carboxylic acids having 14 to 24 carbon atoms, fatty alcohols having 14 to 24 carbon a~oms and mixtures thereof.

The mono-carboxylic acids may be used as 50 100%
sodium or potassium soap.
A particularly preferred component B is linoleic acid, since linoleic acid assists in the absorption of ultraviolet light and furthermore is a vital component of the natural skin lipids constituting the moisture barrier in the stratum corneum.

Component B may comprise a mixture of compounds, for example a fatty acid mixture of palmitic, oleic and stearic acid at 3:2:1 by weight may be employed, however particularly useful fatty acids from the point of view of availability are linoleic and stearic acid.

component c Component C is a compound capable of stabilising any lipid bilayers which may be formed in the composition.

Suitable compounds may be selected from 3~-sterols;
squalene; squalane; saponins or sapogenins of the plant steroid or triterpenoid type; di and tri terpenes such as phytol, retinol and amyrin; and mixtures thereo~.

:' ' ~r~91 ~ J32~7 Preferably component C is a 3~ sterol having a tail on the 17 position and having no polar groups, for example cholesterol, sitostero]., stigmast~rol and ergosterol.

A particularly preferred component C is the 3~-sterol ergosterol since this is well known to convert in situ into vitamin D2 (calciferol) on reception of ultraviolet liyht.

It is essential that the molar ratio in which the components A, B and C are present is from 1:1.5 to 6.0:1.1 to 8.0 respectively, in order to ensure adequate control o~
water flux.

Preferably components A, B and C are present from 1:1.5 to 400:1.1 to 4.0 respectivsly and most preferably from 1:1.8 to 3.6:1.2 to 3Ø

The composition according to the invention may include a cosmetically acceptable vehicle to act as dilutant, dispersant or carrier for the components. Suitable vehicles include water, squalene, squalane, volatile silicone, liquid or solid emollients, solvents, humectants, thickeners and powdPrs.

Preferably the composition includes up to 5% by weight humectant, either as the vehicle or in addition to another vehicle, most preferably the humectant is glycerol.

Examples of particular mixtures include:
(i) A - Distearyl lecithin phospholipid B - Octadecanol C - Stigmasterol (ii) A - Ceramide II (having two C16 chains) B - a long chain fatty acid of C16 to C18 C - cholesterol .

, ~' ' . ~ ,.
:. .

9 ~

Use of the Composition The composition according to the invention is intended primarily as a product for topical application to human S skin, especially as an agent for reducing the permeability of the skin to water, particularly when the skin is dry or damaged, in order to reduce moisture loss and generally to enhance the quality and flexibility of the skin. The composition can also be applied to hair and nails.
The composition may be used as a product for topical application to human skin to treat dry or ayeing skin.

In use, a small quantity of the composition, for example from 1 to 5 ml, is applied to exposed areas of the skin, from a suitable container or applicator and, if necessary, it is then spread over and/or rubbed into the skin using the hand or fingers or a suitable device.

Examples The invention is illustrated by the following examples.

Examples 1-15: Comparative Examples A-F

Compositions formulated according to the invention were tested to measure the reduction in water flux by the following method.
In Vitro Measurement of Water Vapour Transmission Rate The reduction in water permeability of the skin following topical application of the composition according to the invPntion can be determined by in vitro measurement of the water vapour transmission rate (WVTR) using a water transmission cell adapted from that described by Blank X H, J Invest Dermatol, [1952], 18, 433-440.

. :

"'' ~' ` ' ' . '' 1' ' ''~ ' ' ' ~8 ~69~

- 13 - J32~7 _retreatment of Porcine Stratum Corneum Isolated porcine stratum corneum was floated on propan-2-ol contained in a glass petri dish. The dish was gently agitated for 1 hour at 40C and the sample of extracted stratum corneum was then removed, floated in saline ~olution onto spectra mesh and air dried overnight.

Measurement of Initial WVTR Prior to Treatment 750 ~l distilled waker was placed in the centre well of the cell and a sample o~ pretreated stratum corneum (see above) was care~ully laid onto a stainless steel grid over the well ensuring that the stratum corneum completely covered the 0-ring, such that a watertight seal was achieved. Care was taken to avoid wrinkles, tears and holes in the stratum corneum sample. The top of the transmission cell was then screwed into position and allowed to equilibrate at xoom temperature be~ore an initial measurement was made. The cell was weighed after 5 minutes, then placed in an incubator at 37C, 5% RH. Two further weight measur~ments were taken at suitable intervals over a period of 24 hours at the end of which time a test or control solution was applied and three more measurements were taken during a further 21 hours. Five cells were used for each test or control treatment.

Study of the Effect of Topical Ap~lication of Test Material For each test, a solution of test material in chloroform/methanol (2:1 v/v) was prepared at 15 mg/ml concentration. 15 ~l of this solution was applied to the previously selected propan-2-ol extracted skin samples as described above. The chloroform/methanol quickly evaporated. The five cells containing the skin samples were weighed after 5 minutes prior to placing in the incubator at 37C, 5% RH. As mentioned above, three weight ;~37~9~
~ J32~7 measurements were then taken at intervals over a period of 21 hours.

A control measurement was made using other selected skin samples. This was carried out in the same way using an equal guantity of chloroform/methanol (2:1) containing no test material.

Calculation of the WVTR
The WVTR was calculated for each sample (pre and post topical application) as follows:

wei.ght loss WVTR (mg/cm2/hr) Area of exposed tissue x time The mean WVTR for each group of cells was then calculated from these values. The ~tandard deviation was calculated from the observed changes (relative increase or decrease) in WVTR measured before and after the topical application. It was then determined whether any obssrved reduction in WVTR was significant compared to the control measurement by use of the Duncan's Multiple Range Test.
Results are shown in table 1, structures mentioned in this table are as follows.

Structure 8 o o Il 11 C~H37 - O - C - CH - CH2 - C(OC2H4) 7-8EO - OH
I (8) ClsH31 -- CH2 . . :

~)87~ ~

St.ructure 9 O O
Il 11 C22H4s - O - C - CH - CH2 -- C(OC2H4) 7-8EO - OH
(9) ClsH3l -- CH2 Structure 10 Il I . , C6Hl3 - CHOH - C - N ~ CH2 (10) I

CHOH
I

Structure 11 Il I
C14H29 - CHOH - C - N - CH2 (11) I

CHOH
I

C16H33 -- -- C~2 Structure 12 Il I .
Cl5H31 - C - N - CH2 (12~.
I

CHOH
I

.,. , ~ .

, ~8~ ~3 ,~ ~.1 _ _ _ ___ ~____ __ -rl h h .r~-r~ O O
.r U) Ul U'l U~11~ Ul Ul U~ U~ ~
.rl ~ 1 Q) Q~ a) ~I) ~D ~D Q) a) a) Q) U~ h ~ ~ :.~ ~ :~ ~1 :>~ :>~ :>~ ~ :~
__ __ _ ,~ . ~ ~o ,~ ,~
h h O V V h h O O
~1 h . . Q) a) ~ .~) Ul ~ a) ~-J,~ o ~ u~ u~
,_1 ~ O r\ rl ~ --1 r~l o _, a~ ~ ~ V ,~ ,~ o o ~ V ~ ~ .~ ~0 ~ ~ ~
.. V ~ h ,~ .. ..
.. O(~ h .. ..
~ .. ~ a) tO ~ ~c~
,~ ~ rl r~ ~U Ul ~ .,1 r l V t~
o 1~v ~ .. u~ ~ v ~a a .,~ ~ ~ .. ~
O h ~ . . U V
t~ r~ V fd ~ ~r1 _ O V r~ r l s l O,~ a) O o ~ ,~ .~ h ~1 ,-1h ~ la ~` o ~1 5-1 d S~ O~0 ~J U Ir) N 11;1~1 rt r~~ ~ r~ ~ U~ ~ .,~ U~ U~
~ r-l U~ ~ h `_ _ U~ U~ .. ..
_, .... 'C~ O 1-1 ~1 ~- ~
o ~ a) a) o ~ 1 ~ H ~ ~1 ~ U~ ~ U~ ^ ~) ~ ~) ~ O~ _.. t ~ _~ ~1 r-l O H 1~H 1~ OO ts~ Ul 10 Ul ~ ~1 N
.r1 ~ . . . ~ . . ~ aJ ~I) ~ a) ~ a) t~ ~U N t~ ~) t~) ~ h ~ ~1 ~r h ~ )-~1 ~c) - ~ - x - x ~ ~ .. a) - ~ ,~ ~ ,~ ~
w ,~ 1 ,~ ~-1 ~ a~ (~ a~ u~ ul 1` ~ 01:) ,IJ 00 ~ ~ ~
O ~ ~ ~ ~ ~ ~ ~ ~ O ~ O ~ V ~ O O ~ V
0 ~I d' h U) ~ ) ~ 1 ~ ~r ~
~3 h - ~ h ~ ~ O ~ ~ U ~ - h ~ ~ ~ . . )~ ~ ~ h o a) ~ a) r1 al ~1 a) r-l ~ ~ ,~--I ~ r-l ~ rJ ~ r-l C~ ~_ O~- V~ O I U~~ U~~ U~~ U~~
_ _ _ _ , _ _ _ r,~ r~ ,:
a) ~
r4 ~ O
~ ~ ~,~ ~ ~~r ~ ~o ~ o~ ~ ~
E~ _ _ _ , , .. , " :

:- :, . . ...
. .~ ~,: :" , . .

. -. : .: . . ~ . :

i~O~Ç;~
'~` - - - - - - ~ - - - -- -- - ~
~ .o .o ~ ~

a ~ z z z z; z z ~ __ _ , V .

R O O
,1 ~
~ ~ O
V '~o ~
E~ ~

ô .. ~ ~ ~' S

; S ¦ e ~ a~ ~ S

S ~ ~ v In ~ ~ 0 j i S--1 ~ V ~

L~ ,, N _ _ ~ _ 0 ____ _ '` ' ' ~ ': ' ,

Claims (10)

1. A cosmetic composition comprising three components A, B and C, wherein A is a molecule having at least two hydrocarbon chains and a polar head group for which:

;
component B is a molecule having one long hydrocarbon chain and a polar head group; and component C is capable of assisting the formation of lipid bilayers and stabilising any lipid bilayers formed in the composition; providing that the molar ratio of A:B:C is 1:1.5 to 6.0:1.1 to 8Ø
2. A cosmetic composition according to claim 1 wherein the molar ratio of A:B:C is 1:1.5 to 4.0:1.1 to 4Ø
3. A cosmetic composition according to claim 1 wherein component A is selected from the group consisting of ceramides; pseudoceramides; phospholipids; glycolipids having a structure of two or more acyl or alkyl long chains suitably containing from 14 to 50 carbon atoms attached to a polar head group; specific esters of polyethylene glycol;
polyglycerol-n-x-oleate; sorbitan dioleate; sorbitan sesquioleate; long chain alkyl ether versions of phospholipids and glycolipids; and mixtures thereof.
4. A cosmetic composition according to claim 1 wherein component B is selected from the group consisting of straight-chained mono carboxylic acids having 14 to 30 carbon atoms, straight chained fatty alcohols having 14 to carbon atoms, sugar esters, alkylated sugars and mixtures thereof.
5. A cosmetic composition according to claim 1 wherein component C is selected from the group consisting of 3.beta.-sterols; squalene; squalane; saponins or sapogenins of the plant sterol or triterpenoid type; di and tri terpenes; and mixtures thereof.
6. A cosmetic composition according to claim 1 wherein the composition additionally comprises a cosmetically acceptable vehicle.
7. A cosmetic composition according to claim 1 wherein the composition additionally comprises up to 5% by weight humectant.
8. A cosmetic composition according to claim 7 wherein the humectant is glycerol.
9. The use of a composition according to claim 1 in the topical treatment of dry, ageing or detergent damaged human skin or hair.
10. A cosmetic composition as claimed in claim 1 and substantially as described herein.
CA002087691A 1992-01-23 1993-01-20 Cosmetic compositon Abandoned CA2087691A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB929201476A GB9201476D0 (en) 1992-01-23 1992-01-23 Cosmetic compositions
GB929226690A GB9226690D0 (en) 1992-12-22 1992-12-22 Cosmetic composition
GB9201476.0 1992-12-22
GB9226690.7 1992-12-22

Publications (1)

Publication Number Publication Date
CA2087691A1 true CA2087691A1 (en) 1993-07-24

Family

ID=26300198

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002087691A Abandoned CA2087691A1 (en) 1992-01-23 1993-01-20 Cosmetic compositon

Country Status (6)

Country Link
EP (1) EP0556957A1 (en)
JP (1) JPH0680555A (en)
KR (1) KR930016085A (en)
AU (1) AU652882B2 (en)
BR (1) BR9300262A (en)
CA (1) CA2087691A1 (en)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643899A (en) * 1992-06-19 1997-07-01 Cellegy Pharmaceuticals, Inc. Lipids for epidermal moisturization and repair of barrier function
GB9220268D0 (en) * 1992-09-25 1992-11-11 Unilever Plc Cosmetic composition
FR2710527B1 (en) * 1993-09-30 1995-12-08 Roussel Uclaf New cosmetic and dermatological compositions combining ceramides and linoleic acid, their preparation.
US5876697A (en) * 1994-08-04 1999-03-02 Gakko Houjin Toin Gakuen Method for the production of microbubble-type ultrasonic contrast agent using fatty acid surfactants
GB9421185D0 (en) * 1994-10-20 1994-12-07 Unilever Plc Personal car composition
FR2729572A1 (en) * 1995-01-20 1996-07-26 Oreal USE OF CERAMIDES AS A THICKENING AGENT
FR2730410B1 (en) * 1995-02-15 1997-03-21 Oreal COSMETIC COMPOSITION COMPRISING A COMBINATION OF CERAMIDES AND ITS USE
FR2734721B1 (en) * 1995-06-02 1997-08-14 Clarins DAY COSMETIC PREPARATION ACTIVATED BY LIGHT AND INTENDED TO FIGHT AGAINST SKIN AGING
US5738856A (en) * 1995-11-03 1998-04-14 Ocular Research Of Boston, Inc. Skin care preparation and method
GB9602111D0 (en) * 1996-02-02 1996-04-03 Unilever Plc Personal care composition
GB9602608D0 (en) 1996-02-09 1996-04-10 Unilever Plc Fabric softening composition
FR2753200B1 (en) * 1996-09-06 1998-12-04 Fabre Pierre Dermo Cosmetique PROCESS FOR THE EXTRACTION OF LIPIDS FROM SOY LECITHIN, LIPID EXTRACT OBTAINED AND DERMATO-COSMETIC COMPOSITIONS CONTAINING THE SAME
GB9821778D0 (en) 1998-10-06 1998-12-02 Unilever Plc Process and apparatus for the production of a deodorant or antiperspirant composition
US6126954A (en) 1999-04-05 2000-10-03 Unilever Home & Personal Care Usa, Division Of Conopco Liquid compositions comprising stable emulsion of small particle skin benefit agent
US6440908B2 (en) 1999-11-30 2002-08-27 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. High moisture retaining bars compositions comprising borax as water structurant
GB0008392D0 (en) 2000-04-05 2000-05-24 Unilever Plc Process for the production of a deodorant or antiperspirant product
US6365138B1 (en) * 2000-04-07 2002-04-02 The Regents Of The University Of California Compositions for metabolic protection and repair of lips
US6660699B2 (en) 2001-09-28 2003-12-09 Unilever Home & Personal Care Usa Toilet bar having a latent acidifier
JP2005509610A (en) * 2001-10-04 2005-04-14 ユニリーバー・ナームローゼ・ベンノートシヤープ Increased skin epidermal barrier development
WO2006023201A1 (en) 2004-08-16 2006-03-02 Union Carbide Chemicals & Plastics Technology Corporation Personal care composition
EP1838280A2 (en) 2005-01-10 2007-10-03 Dow Global Technologies Inc. Personal care compositions
US8772212B2 (en) 2008-08-07 2014-07-08 Conopco, Inc. Liquid personal cleansing composition
WO2011036174A1 (en) 2009-09-25 2011-03-31 B.R.A.I.N. Biotechnology Research And Information Network Ag A novel method for the production of a antimicrobial peptide
US8017566B2 (en) 2009-11-13 2011-09-13 Conopco, Inc. Liquid personal cleansing composition
WO2014170186A1 (en) 2013-04-16 2014-10-23 Unilever Plc Liquid soap having enhanced antibacterial activity
BR112016013819B1 (en) 2014-01-29 2022-06-07 Unilever Ip Holdings B.V. Cleaning composition and use of a polymer
DE212015000054U1 (en) 2014-01-29 2016-09-21 Unilever N.V. Cleaning compositions containing stable silver
DE212015000053U1 (en) 2014-01-29 2016-09-07 Unilever N.V. Oligodynamic metal-containing aqueous composition
EP3328981B1 (en) 2015-07-29 2022-01-26 Unilever Global IP Limited Cleansing composition with improved availability of benefit agent
CN109803532A (en) 2016-10-07 2019-05-24 荷兰联合利华有限公司 Personal cleansing thimerosal
CA3047186A1 (en) 2016-12-21 2018-06-28 Unilever Plc Liquid personal cleansing composition
EA038465B1 (en) 2016-12-27 2021-09-01 ЮНИЛЕВЕР АйПи ХОЛДИНГС Б.В. Antimicrobial composition
BR112019021301B1 (en) 2017-05-08 2022-12-13 Unilever Ip Holdings B.V. LAMELLAR PERSONAL CLEANING COMPOSITION
WO2019086275A1 (en) 2017-11-03 2019-05-09 Unilever Plc Skin cleansing composition and method of use
DE202018102949U1 (en) 2018-05-25 2018-06-15 Aerox AG Foam Oil Shower
CA3120935A1 (en) * 2018-11-27 2020-06-04 Hollister Incorporated Skin protectant film including skin health ingredients
US20200375854A1 (en) 2019-05-31 2020-12-03 L'oreal Compositions and methods for treating keratinous substrates
US20220323308A1 (en) 2019-08-07 2022-10-13 Mary Kay Inc. Dissolvable vitamin c and retinol film
WO2021163310A1 (en) 2020-02-12 2021-08-19 Curan Mehra Water-soluble refill dose article enclosing a concentrated liquid cleanser composition and kits having same
WO2021163305A1 (en) 2020-02-12 2021-08-19 Curan Mehra Water-soluble refill dose article enclosing a concentrated cleanser composition and kits having same
DE202021004226U1 (en) 2020-04-23 2023-03-21 Mary Kay, Inc. topical cosmetic compositions
BR112022019870A2 (en) 2020-05-04 2022-11-22 Unilever Ip Holdings B V ANTIMICROBIAL CLEANING COMPOSITIONS
EP4236909A1 (en) 2020-10-30 2023-09-06 Mary Kay, Inc. Instant effect eye cream
CA3196192A1 (en) 2020-11-09 2022-05-12 Michael Gerard Clarke Cleansing compositions comprising a fatty acid and soap mixture and method for making a cleansing bar comprising said mixture
US11268054B1 (en) 2021-01-11 2022-03-08 Hayden Products Llc Single chamber water-soluble refill dose article enclosing a concentrated cleanser composition and kits having same
WO2023279086A1 (en) 2021-07-01 2023-01-05 Mary Kay Inc. Topical composition against fine lines and wrinkles
WO2023052124A1 (en) 2021-09-28 2023-04-06 Unilever Ip Holdings B.V. Cleansing composition
WO2024056586A2 (en) 2022-09-16 2024-03-21 Unilever Ip Holdings B.V. Self-foaming cleansing composition

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57209207A (en) * 1981-06-17 1982-12-22 Kanebo Ltd Creamy or milky skin cosmetic
FR2521565B1 (en) * 1982-02-17 1985-07-05 Dior Sa Parfums Christian PULVERULENT MIXTURE OF LIPID COMPONENTS AND HYDROPHOBIC CONSTITUENTS, METHOD FOR PREPARING SAME, HYDRATED LIPID LAMELLAR PHASES AND MANUFACTURING METHOD, PHARMACEUTICAL OR COSMETIC COMPOSITIONS COMPRISING HYDRATED LAMID PHASES
IL79114A (en) * 1985-08-07 1990-09-17 Allergan Pharma Method and composition for making liposomes
JPS63192703A (en) * 1987-02-04 1988-08-10 Kao Corp External agent for skin
EP0282816B1 (en) * 1987-03-06 1993-09-15 Kao Corporation External skin care preparation
WO1990001323A1 (en) * 1988-08-12 1990-02-22 Bernstein Joel E Method and composition for treating and preventing dry skin disorders
JPH0347108A (en) * 1989-04-05 1991-02-28 Kao Corp Double-emulsified cosmetic composition
JPH0374312A (en) * 1989-08-10 1991-03-28 Kao Corp Cosmetic
JPH0818948B2 (en) * 1990-08-31 1996-02-28 花王株式会社 Aqueous cosmetic and its manufacturing method

Also Published As

Publication number Publication date
EP0556957A1 (en) 1993-08-25
KR930016085A (en) 1993-08-26
AU3201593A (en) 1993-08-12
BR9300262A (en) 1993-09-28
JPH0680555A (en) 1994-03-22
AU652882B2 (en) 1994-09-08

Similar Documents

Publication Publication Date Title
CA2087691A1 (en) Cosmetic compositon
Bouwstra et al. The role of ceramides 1 and 2 in the stratum corneum lipid organisation
Gray et al. Different populations of pig epidermal cells: isolation and lipid composition.
US5688752A (en) Aqueous personal care cleanser comprising specific lipid composition
CA1045979A (en) Moisturizing compositions
Gray et al. Lipid compositions of cells isolated from pig, human, and rat epidermis.
ES2013792A6 (en) External agent for skin
EP0482860A1 (en) Cosmetic composition
JP5657191B2 (en) Vesicle and topical skin preparation containing the same
EP0495624A1 (en) Cosmetic composition
EP0741562A1 (en) Topical application of ceramides
EP0587288A1 (en) Cosmetic composition containing a lipid and a hydroxy or ketacarboxylic acid
Wertz et al. Covalent attachment of ω-hydroxyacid derivatives to epidermal macromolecules: a preliminary characterization
KR100545836B1 (en) Cosmetic composition for skin irritation relief containing nanoliposomes of intracellular lipid components
Squier et al. Thin-layer chromatographic analyses of lipids in different layers of porcine epidermis and oral epithelium
WO2001076538A1 (en) Compositions for metabolic protection and repair of lips
AU2001249884A1 (en) Compositions for metabolic protection and repair of lips
EP0699181B1 (en) Linoleoylamide based ceramide derivative and its use in cosmetic preparations for the treatment of dry skin
EP0731785B1 (en) Ceramide 3 derivatives based on monounsaturated fatty acids
KR100263623B1 (en) Moisturing cosmetic compositions
KR20070071500A (en) Stabilized nanovesicle containing oleaginous components and transparent cosmetic composition comprising the same
JPH10175843A (en) Cosmetic for skin
CA2386732C (en) Compositions comprising fluid petrolatum and methods for the use thereof
Vinson et al. Basic studies in percutaneous absorption
KR100501341B1 (en) Novel Opacifier and Cosmetic Composition Comprising the Same

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead